Cell Death and Disease · 2017 · 13 citations · 10 references
MedicineImmunologyOncologyCancer ImmunologyImmunotherapyMolecular OncologyCancer ImmunotherapyCombination ImmunotherapyImmunogenic Cell DeathImmunotherapy For Solid TumorsInterferon-based TherapyOncogenic Signaling PathwaysAblation-induced Immunogenic Cell DeathAntitumor Interferon ResponsesCancer Immunotherapy ResistanceImmunogenic Cell Death InductionInterferon Pathway GenesInterferon Pathway GeneticsType Ii Interferon Signaling
Cancer immunotherapy is a wide-ranging term that includes many strategies to reestablish or activate an effector antitumor immunity cycle. Among the most successful approaches, PD-1/PDL-1 and CTLA-4 checkpoint blockade and chimeric antigen receptor (CAR) T cells have provided undeniable evidence of the potential of immunotherapy for several types of cancer, including metastatic melanoma. 1
10
Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy
Heng Yang, Yuting Ma, Guo Chen et al. · OncoImmunology · 2016 · 183 citations · Full text
Medicine, Cancer Biology, Oncology +17